/

Empresas

Na

No verificado

Navigator Medicines, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosMercado laboralSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa

29/05/2025

Biotecnología

Sanidad

Salud

Farmacéutica

Medicina - Varios

Industria

Navigator Medicines Announces First Participants Dosed in a Phase 1b Trial of NAV-240, a Potential Best-in-Class Anti-OX40L and Anti-TNFα Bispecific Antibody Therapeutic for Autoimmune Diseases

Fuente

Navigator Medicines, Inc.

Editor

1.00

0

05/03/2025

Biotecnología

Farmacéutica

Salud

Medicina - Varios

Eventos

Navigator Medicines to Present Data at the American Academy of Dermatology (AAD) Annual Meeting

Fuente

Navigator Medicines, Inc.

Editor

1.00

0

11/02/2025

Biotecnología

Farmacéutica

Salud

Medicina - Varios

Mercado laboral

Navigator Medicines Appoints Tausif ‘Tosh’ Butt as Chief Executive Officer and Khurem Farooq as Chairman of the Board of Directors

Fuente

Navigator Medicines, Inc.

Editor

1.00

0

27/08/2024

Biotecnología

Farmacéutica

Salud

Mercado laboral

Navigator Medicines Announces $100 Million Series A Financing and In-Licensing of NAV-240, a Potential Best-in-Class Anti-OX40L and Anti-TNFα Bispecific Antibody Therapeutic for Autoimmune Diseases

Fuente

Navigator Medicines, Inc.

Editor

1.00

0

Seguidores

0

Compatibilidad

0